PsilodexMedication × psilocybin
Your list , 0 items
Medication class

IL-17 and IL-23 blockers and psilocybin.

10 records in this group. None has published human data with psilocybin or another classic psychedelic; the rest draw on each medication's own pharmacology and label. State rules are summarized for Colorado, Oregon and New Mexico.

10Records
0With human data

Also searched as IL-17 blocker · IL-17 blockers · IL-17 inhibitor · IL-23 blocker · IL-23 blockers · IL-23 inhibitor · interleukin blocker · interleukin inhibitor

01 What the evidence covers

Best evidence available per medication
10No psilocybin data
No psilocybin data: no human data with psilocybin or another classic psychedelic; the text draws on the medication's own pharmacology and its label or reference facts

02 Each medication

A to Z
  • Bimekizumab · BimzelxEvidence: No psilocybin data

    Plaque psoriasis; Psoriatic arthritis

    Not studied with psilocybin; no linking mechanism is described. Also, its label warns of infections and of suicidal thoughts and behavior.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Brodalumab · SiliqEvidence: No psilocybin data

    Moderate-to-severe plaque psoriasis (adults, after other systemic therapies)

    Not studied with psilocybin; no linking mechanism is described. Also, its boxed warning covers suicidal thoughts and behavior.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Guselkumab · TremfyaEvidence: No psilocybin data

    Plaque psoriasis; Psoriatic arthritis

    Not studied with psilocybin; no linking mechanism is described. Also, it acts on the immune system.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Icotrokinra · IcotydeEvidence: No psilocybin data

    Moderate-to-severe plaque psoriasis (adults and children 12 years and older, at least 40 kg)

    Not studied with psilocybin; no linking mechanism is described. Also, it acts on the immune system.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Ixekizumab · TaltzEvidence: No psilocybin data

    Plaque psoriasis; Psoriatic arthritis

    Not studied with psilocybin; no linking mechanism is described. Also, it acts on the immune system.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Mirikizumab · OmvohEvidence: No psilocybin data

    Ulcerative colitis; Crohn's disease

    Not studied with psilocybin; no linking mechanism is described. Also, it acts on the immune system.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Risankizumab · SkyriziEvidence: No psilocybin data

    Plaque psoriasis; Psoriatic arthritis

    Not studied with psilocybin; no linking mechanism is described. Also, it acts on the immune system.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Secukinumab · CosentyxEvidence: No psilocybin data

    Moderate-to-severe plaque psoriasis; Psoriatic arthritis

    Not studied with psilocybin; no linking mechanism is described. Also, it acts on the immune system.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Tildrakizumab · IlumyaEvidence: No psilocybin data

    Moderate-to-severe plaque psoriasis; Psoriatic arthritis

    Not studied with psilocybin; no linking mechanism is described. Also, it acts on the immune system.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Ustekinumab · Stelara, Wezlana, Selarsdi, Pyzchiva, Otulfi, Imuldosa, Yesintek, Steqeyma, StarjemzaEvidence: No psilocybin data

    Plaque psoriasis (adults and children 6 years and older); Psoriatic arthritis (adults and children 6 years and older)

    Not studied with psilocybin; no linking mechanism is described. Also, it acts on the immune system.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

03 Properties the records flag

Records with each flag
2Psychiatric reactions

Flags describe a medication's own properties, each cited in its record. A flag is not a finding about any combination. Definitions are on the Method page.

04 State rules

Official text governs
COColorado · final · checked 2026-10-24

No provision names these medications or this group.

OROregon · final · checked 2026-10-24

No provision names these medications or this group.

NMNew Mexico · pending · checked 2026-10-24

Rules not final; the proposed rules reviewed name no medication in this group.

05 Studies cited in this group

Records citing each
10Halman A, Kong G, Sarris J, Perkins D. Drug–drug interactions involving classic psychedelics: a systematic review. J Psychopharmacol 2024;38(1):3–18.
10Sarparast A, Thomas K, Malcolm B, Stauffer CS. Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology 2022;239(6):1945–1976.

Records reviewed 2026-11-02 to 2026-11-09. Each row summarizes one record; the full record, with every source, opens in the browser and is not sent to the server. All classes · Browse A–Z

AgreementPsilodex

Before you use Psilodex

Check each box to continue.

Your searches, your list and the medications you look up stay in this browser. We can't see them. Privacy · Emergency: 911 · Mental health crisis: call or text 988 · Poison Control: 1-800-222-1222

Terms version 2026-10-25